Seres Therapeutics Inc. (MCRB)
NASDAQ: MCRB
· Real-Time Price · USD
19.44
1.12 (6.11%)
At close: Aug 22, 2025, 3:59 PM
19.44
0.00%
After-hours: Aug 22, 2025, 07:56 PM EDT
Seres Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 5.96M | 5.96M | 5.96M | 64K | 374K | 126.85M | 126.33M | 127.24M | 130.37M | 5.11M | 7.13M | 13.37M | 136.66M | 140.7M | 144.93M | 155.27M | 29.96M | 30.74M |
Cost of Revenue | 8.97M | 9.33M | 7.36M | 8.44M | 8.72M | 9.4M | 11.45M | 8.4M | 49.83M | 91.66M | 89.03M | 124.78M | 82.79M | 74.81M | 103.14M | 91.25M | 113.98M | 98.13M |
Gross Profit | -3.01M | -3.37M | -1.4M | -8.37M | -8.65M | 117.14M | 114.56M | 118.53M | 80.54M | -86.55M | -81.9M | -111.41M | 53.87M | 65.89M | 41.79M | 64.02M | -84.02M | -67.39M |
Operating Income | -110.12M | -114.11M | -124.04M | -134.74M | -152.98M | -74.58M | -107.98M | -136.76M | -148.46M | -261.31M | -246.49M | -227.62M | -100.1M | -84.92M | -64.49M | -32.96M | -131.36M | -103.76M |
Interest Income | 2.25M | 2.94M | 3.97M | 5.5M | 7.42M | 7.92M | 7.3M | 6.74M | 5.04M | 3.71M | 3.06M | 2.13M | 1.85M | 2.29M | 2.87M | 3M | 2.51M | 1.75M |
Pretax Income | -53.84M | -66.86M | -139.68M | -158.75M | -155.57M | -76.15M | -107.19M | -141.27M | -153.42M | -264.71M | -250.16M | -231.36M | -103.14M | -86.74M | -65.58M | -33.83M | -132.33M | -104.71M |
Net Income | 85.97M | 72.95M | 136K | -25.48M | -162.1M | -82.68M | -114.33M | -142.37M | -154.51M | -265.8M | -251.52M | -232.24M | -104.02M | -87.61M | -65.58M | -33.83M | -132.33M | -104.71M |
Selling & General & Admin | 47.31M | 48.7M | 50.72M | 41.74M | 48.46M | 64.87M | 73.43M | 92.36M | 91.31M | 83.59M | 79.69M | 77.8M | 78.97M | 76.09M | 69.26M | 59.35M | 47.34M | 36.38M |
Research & Development | 54.06M | 56.93M | 66.81M | 77.01M | 85.7M | 116.69M | 138.96M | 162.13M | 180.1M | 177.24M | 172.92M | 163.45M | 160.22M | 152.24M | 141.89M | 130.01M | 113.98M | 98.13M |
Other Expenses | 4.16M | 3.53M | 3.53M | n/a | -1.68M | -3.19M | 412K | 1.07M | 2.72M | 3.93M | -655K | -1.63M | -1.63M | -1.61M | -1.04M | -937K | -557K | 204K |
Operating Expenses | 105.54M | 109.17M | 121.06M | 118.75M | 132.48M | 181.98M | 216.42M | 259.18M | 278.83M | 266.42M | 253.62M | 240.99M | 236.76M | 225.62M | 209.42M | 188.23M | 161.32M | 134.51M |
Interest Expense | n/a | 3.45M | 8.11M | 12.14M | 16.15M | 15.89M | 13.18M | 11.03M | 8.74M | 7.06M | 6.02M | 4.88M | 3.9M | 3.13M | 2.91M | 2.93M | 2.92M | 2.9M |
Selling & Marketing Expenses | n/a | n/a | -1.56M | -1.56M | -1.56M | -1.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 110.12M | 114.11M | 124.04M | 132.23M | 147.65M | 195.73M | 228.6M | 260.86M | 278.83M | 266.42M | 253.62M | 240.99M | 236.76M | 225.62M | 209.42M | 188.23M | 161.32M | 134.51M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | 149K | 755K | 1.24M | 1.24M | 1.09M | 1.36M | 873K | 873K | 1.32M | 734K | 734K | 734K | 287K |
Shares Outstanding (Basic) | 8.74M | 8.7M | 7.7M | 7.63M | 7.58M | 146.1M | 6.46M | 128.29M | 127.71M | 125.86M | 108.08M | 122.53M | 92.26M | 92.16M | 91.7M | 91.76M | 91.66M | 91.53M |
Shares Outstanding (Diluted) | 8.74M | 8.71M | 7.7M | 7.63M | 7.58M | 146.1M | 6.46M | 128.29M | 129.84M | 125.86M | 108.08M | 122.53M | 92.26M | 92.16M | 91.7M | 94.95M | 91.66M | 91.53M |
EPS (Basic) | 11.26 | 9.19 | 5.16 | 0.61 | -11.36 | -6.66 | -6.96 | -1.13 | -1.25 | -2.31 | -2.36 | -2.35 | -1.12 | -0.95 | -0.72 | -0.4 | -1.5 | -1.25 |
EPS (Diluted) | 11.19 | 9.12 | 5.10 | 0.61 | -11.36 | -6.66 | -6.96 | -1.13 | -1.25 | -2.31 | -2.36 | -2.34 | -1.13 | -0.96 | -0.73 | -0.42 | -1.5 | -1.25 |
EBITDA | -108.21M | -117.42M | -124.09M | -144.71M | -135.03M | -53.59M | -85.43M | -115.89M | -133.3M | -248.29M | -236.67M | -219.78M | -91.14M | -74.95M | -53.45M | -23.11M | -122.81M | -96.3M |
EBIT | -53.84M | -63.41M | -131.56M | -153.15M | -145.95M | -66.79M | -100.55M | -130.25M | -144.68M | -257.65M | -244.14M | -226.48M | -99.25M | -83.61M | -62.67M | -30.9M | -129.41M | -101.81M |
Depreciation & Amortization | 6.63M | 6.99M | 7.47M | 8.44M | 10.92M | 13.2M | 15.11M | 14.35M | 12.21M | 11.44M | 10.6M | 9.84M | 10.41M | 9.72M | 9.22M | 8.2M | 7.45M | 6.91M |